In our research, we found that forced decreased expression of KCNMB2-AS1 would inhibit the expression of CD133, Nanog, Oct4, Sox2, ALDH1 and prevent the ability of stemness of bladder cancer cell lines, which would provide a new target of Bladder cancer treatment. Here, SOX2 is linked to urinary bladder cancer.